|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 179.62 AUD | +0.68% |
|
+2.33% | +4.04% |
| 01-22 | Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality | RE |
| 01-20 | Global drugmakers rush to boost US presence as tariff threat looms | RE |
| Capitalization | 58.79B 50.04B 46.47B 43.57B 81.13B 5,385B 86.02B 531B 210B 2,544B 220B 216B 9,308B | P/E ratio 2026 * |
23.3x | P/E ratio 2027 * | 17.1x |
|---|---|---|---|---|---|
| Enterprise value | 67.57B 57.51B 53.41B 50.08B 93.25B 6,189B 98.86B 610B 242B 2,924B 253B 248B 10,698B | EV / Sales 2026 * |
4.22x | EV / Sales 2027 * | 3.99x |
| Free-Float |
99.9% | Yield 2026 * |
2.52% | Yield 2027 * | 2.75% |
Last Transcript: CSL Limited
| 1 day | +0.68% | ||
| 1 week | +2.33% | ||
| Current month | +4.04% | ||
| 1 month | +2.25% | ||
| 3 months | -17.44% | ||
| 6 months | -32.35% | ||
| Current year | +4.04% |
| 1 week | 173.72 |  | 180.8 |
| 1 month | 168.29 | | 180.8 |
| Current year | 168.29 | | 180.8 |
| 1 year | 168 | | 282.2 |
| 3 years | 168 | | 314.28 |
| 5 years | 168 | | 319.78 |
| 10 years | 91.62 | | 342.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul McKenzie
CEO | Chief Executive Officer | 60 | 06/03/2023 |
Ken Lim
DFI | Director of Finance/CFO | 52 | 07/10/2025 |
Mark Hill
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/10/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 17/10/2018 | |
Marie McDonald
BRD | Director/Board Member | 70 | 14/08/2013 |
Megan Clark
BRD | Director/Board Member | 68 | 16/02/2016 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +0.75% | 2.91% | 26 M€ | |
| +6.67% | 2.49% | 8 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.68% | +2.33% | -33.47% | -39.80% | 58.79B | |
| +0.82% | +1.83% | +11.10% | +4.64% | 77.51B | |
| -5.07% | +77.80% | +77.80% | +77.80% | 56.2B | |
| -0.04% | -2.52% | +40.86% | +236.15% | 57.8B | |
| +0.68% | +3.10% | +21.75% | -39.18% | 25.5B | |
| +0.37% | -0.17% | +45.09% | +26.27% | 20.63B | |
| +4.14% | +31.78% | +34.73% | -73.26% | 20.27B | |
| +2.83% | -6.48% | +164.45% | +81.17% | 18.11B | |
| +2.25% | +4.79% | +122.96% | +847.92% | 15.4B | |
| -0.04% | -.--% | +3.71% | +175.02% | 14.02B | |
| Average | +0.67% | +2.57% | +48.90% | +129.67% | 36.42B | |
| Weighted average by Cap. | +0.04% | +1.06% | +34.97% | +85.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16B 13.61B 12.64B 11.85B 22.07B 1,465B 23.4B 144B 57.2B 692B 59.98B 58.75B 2,533B | 16.71B 14.22B 13.21B 12.38B 23.06B 1,531B 24.45B 151B 59.76B 723B 62.67B 61.38B 2,646B |
| Net income | 2.59B 2.21B 2.05B 1.92B 3.58B 238B 3.8B 23.41B 9.28B 112B 9.73B 9.53B 411B | 3.42B 2.91B 2.71B 2.54B 4.72B 314B 5.01B 30.9B 12.24B 148B 12.84B 12.57B 542B |
| Net Debt | 8.78B 7.47B 6.94B 6.51B 12.12B 804B 12.85B 79.24B 31.4B 380B 32.92B 32.25B 1,390B | 7.91B 6.73B 6.25B 5.86B 10.91B 724B 11.57B 71.37B 28.28B 342B 29.66B 29.05B 1,252B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/01/26 | 179.62 $ | +0.68% | 1,049,115 |
| 22/01/26 | 178.41 $ | +1.31% | 959,000 |
| 21/01/26 | 176.11 $ | -0.33% | 1,094,312 |
| 20/01/26 | 176.70 $ | +0.11% | 896,503 |
| 19/01/26 | 176.50 $ | +0.55% | 529,362 |
Delayed Quote Australian S.E., January 23, 2026 at 09:12 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CSL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition